Olimel E (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel E provides amino acid supplementation that supports several clinical conditions where protein turnover is increased.

• Critical illness: helps maintain nitrogen balance and supports tissue repair.
• Post‑operative recovery: aids in wound healing and muscle preservation.
• Chronic kidney disease on dialysis: supplies essential amino acids lost during treatment.
• Malnutrition in the elderly: improves overall nutritional status.
• Severe burns: contributes to protein synthesis required for skin regeneration.

• The amino acid blend in Olimel E supplies the building blocks required for protein synthesis, stimulates the mTOR pathway and supports nitrogen balance. By providing both essential and conditionally essential amino acids, it facilitates tissue repair, immune function and metabolic homeostasis in states of increased catabolism.

Adverse reactions to amino‑acid mixtures are generally mild and related to the gastrointestinal tract or hypersensitivity.

Common Side Effects

• Nausea: mild, transient upset stomach.
• Diarrhea: loose stools, usually self‑limiting.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: transient alteration in taste perception.
• Headache: mild and short‑lasting.
• Injection site irritation: redness or mild pain if administered via feeding tube.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Hyperammonemia: elevated blood ammonia levels in patients with severe liver dysfunction.
• Metabolic acidosis: rare disturbance of acid‑base balance.
• Severe electrolyte imbalance: uncommon but possible with high‑dose regimens.
• Renal impairment worsening: in patients with pre‑existing kidney disease.
• Thromboembolic events: extremely rare, reported in isolated cases.

When prescribing Olimel E, clinicians should consider patient‑specific factors and monitor for potential complications.

• Renal function: assess baseline kidney performance and adjust dosage if needed.
• Hepatic function: evaluate liver status, especially in patients prone to hyperammonemia.
• Allergic history: verify no known hypersensitivity to any amino acid component.
• Concomitant nutrition: coordinate with total parenteral or enteral nutrition regimens to avoid excess protein.
• Metabolic disorders: use caution in patients with inborn errors of amino‑acid metabolism.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino‑acid mixtures can influence the absorption or metabolism of certain medicines; monitoring is recommended.

Major Interactions (Avoid)

• Levodopa: may reduce central availability of levodopa, diminishing Parkinson's symptom control.
• Anticonvulsants (e.g., phenobarbital): can increase amino‑acid catabolism, lowering therapeutic effect.
• High‑dose insulin: risk of hypoglycaemia when large protein loads shift glucose utilization.

Moderate Interactions (Monitor Closely)

• Thyroid hormones: amino acids may affect thyroid‑binding protein levels, requiring dose checks.
• Warfarin: protein intake changes can alter INR stability.
• Diuretics: increased nitrogen load may impact electrolyte balance.
• Oral contraceptives: potential minor reduction in plasma protein binding.
• Antibiotics (e.g., tetracycline): chelation with calcium in the mixture may reduce absorption.